220 related articles for article (PubMed ID: 25795131)
41. Distribution of Th17 cells and Foxp3-expressing T cells in tumor-infiltrating lymphocytes in patients with uterine cervical cancer.
Hou F; Li Z; Ma D; Zhang W; Zhang Y; Zhang T; Kong B; Cui B
Clin Chim Acta; 2012 Nov; 413(23-24):1848-54. PubMed ID: 22820395
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E
Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488
[TBL] [Abstract][Full Text] [Related]
43. Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6.
Guo D; Chen Y; Wang S; Yu L; Shen Y; Zhong H; Yang Y
Immunology; 2018 May; 154(1):132-143. PubMed ID: 29197065
[TBL] [Abstract][Full Text] [Related]
44. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers.
Kim KJ; Lee KS; Cho HJ; Kim YH; Yang HK; Kim WH; Kang GH
Hum Pathol; 2014 Feb; 45(2):285-93. PubMed ID: 24331841
[TBL] [Abstract][Full Text] [Related]
45. Low intratumoral regulatory T cells and high peritumoral CD8(+) T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy.
Liu L; Zhao G; Wu W; Rong Y; Jin D; Wang D; Lou W; Qin X
Cancer Immunol Immunother; 2016 Jan; 65(1):73-82. PubMed ID: 26646849
[TBL] [Abstract][Full Text] [Related]
46. Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.
O'Callaghan DS; Rexhepaj E; Gately K; Coate L; Delaney D; O'Donnell DM; Kay E; O'Connell F; Gallagher WM; O'Byrne KJ
Eur Respir J; 2015 Dec; 46(6):1762-72. PubMed ID: 26541534
[TBL] [Abstract][Full Text] [Related]
47. [Immunohistological study on HLA class II antigen expression and lymphocyte infiltration in cancer tissues of the uterine cervix].
Nakamura M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar; 44(3):349-56. PubMed ID: 1607758
[TBL] [Abstract][Full Text] [Related]
48. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H
Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142
[TBL] [Abstract][Full Text] [Related]
49. Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma.
Al-Qahtani D; Anil S; Rajendran R
J Oral Pathol Med; 2011 Sep; 40(8):636-42. PubMed ID: 21352381
[TBL] [Abstract][Full Text] [Related]
50. In situ observation of the effects of local irradiation on cytotoxic and regulatory T lymphocytes in cervical cancer tissue.
Qinfeng S; Depu W; Xiaofeng Y; Shah W; Hongwei C; Yili W
Radiat Res; 2013 May; 179(5):584-9. PubMed ID: 23510275
[TBL] [Abstract][Full Text] [Related]
51. Characterization of the tumor immune-microenvironment of lung adenocarcinoma associated with usual interstitial pneumonia.
Ueda T; Aokage K; Mimaki S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Kusumoto M; Suzuki K; Tsuchihara K; Nishikawa H; Goto K; Tsuboi M; Ishii G
Lung Cancer; 2018 Dec; 126():162-169. PubMed ID: 30527182
[TBL] [Abstract][Full Text] [Related]
52. IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas.
Cui G; Li Z; Ren J; Yuan A
Virchows Arch; 2019 Nov; 475(5):579-586. PubMed ID: 31062086
[TBL] [Abstract][Full Text] [Related]
53. Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma.
Wang F; Jing X; Li G; Wang T; Yang B; Zhu Z; Gao Y; Zhang Q; Yang Y; Wang Y; Wang P; Du Z
Liver Int; 2012 Apr; 32(4):644-55. PubMed ID: 22118340
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma.
Marchenko S; Piwonski I; Hoffmann I; Sinn BV; Kunze CA; Monjé N; Pohl J; Kulbe H; Schmitt WD; Darb-Esfahani S; Braicu EI; von Brünneck AC; Sehouli J; Denkert C; Horst D; Jöhrens K; Taube ET
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2523-2536. PubMed ID: 35763108
[TBL] [Abstract][Full Text] [Related]
55. Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes.
Xia M; Zhao MQ; Wu K; Lin XY; Liu Y; Qin YJ
J Int Med Res; 2013 Aug; 41(4):1002-8. PubMed ID: 23760912
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
Hiraoka N; Onozato K; Kosuge T; Hirohashi S
Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676
[TBL] [Abstract][Full Text] [Related]
57. Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer.
Iida T; Iwahashi M; Katsuda M; Ishida K; Nakamori M; Nakamura M; Naka T; Ojima T; Ueda K; Hayata K; Nakamura Y; Yamaue H
Oncol Rep; 2011 May; 25(5):1271-7. PubMed ID: 21369705
[TBL] [Abstract][Full Text] [Related]
58. Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas.
Kayser G; Schulte-Uentrop L; Sienel W; Werner M; Fisch P; Passlick B; Zur Hausen A; Stremmel C
Lung Cancer; 2012 Jun; 76(3):445-51. PubMed ID: 22300751
[TBL] [Abstract][Full Text] [Related]
59. Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer.
Xu L; Xu W; Qiu S; Xiong S
Clin Immunol; 2010 Jun; 135(3):466-75. PubMed ID: 20181533
[TBL] [Abstract][Full Text] [Related]
60. Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway.
Suh JH; Won KY; Kim GY; Bae GE; Lim SJ; Sung JY; Park YK; Kim YW; Lee J
Int J Clin Exp Pathol; 2015; 8(11):14608-18. PubMed ID: 26823784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
